Independent Investors Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.1M | Sell |
40,274
-4,400
| -10% | -$947K | 1.94% | 6 |
|
|
2026
Q1 | $9.72M | Sell |
44,674
-500
| -1% | -$111K | 1.93% | 7 |
|
|
2025
Q4 | $10.3M | Hold |
45,174
| – | – | 1.92% | 5 |
|
|
2025
Q3 | $10.5M | Sell |
45,174
-214
| -0.5% | -$43.6K | 2.01% | 5 |
|
|
2025
Q2 | $8.42M | Hold |
45,388
| – | – | 1.84% | 7 |
|
|
2025
Q1 | $9.51M | Hold |
45,388
| – | – | 2.02% | 6 |
|
|
2024
Q4 | $8.07M | Hold |
45,388
| – | – | 1.6% | 8 |
|
|
2024
Q3 | $8.96M | Hold |
45,388
| – | – | 1.82% | 8 |
|
|
2024
Q2 | $7.78M | Hold |
45,388
| – | – | 1.71% | 9 |
|
|
2024
Q1 | $8.27M | Hold |
45,388
| – | – | 1.98% | 9 |
|
|
2023
Q4 | $7.03M | Hold |
45,388
| – | – | 1.62% | 10 |
|
|
2023
Q3 | $6.77M | Hold |
45,388
| – | – | 1.72% | 10 |
|
|
2023
Q2 | $6.12M | Sell |
45,388
-26
| -0.1% | -$3.81K | 1.42% | 12 |
|
|
2023
Q1 | $7.24M | Hold |
45,414
| – | – | 1.8% | 10 |
|
|
2022
Q4 | $7.34M | Hold |
45,414
| – | – | 2.04% | 9 |
|
|
2022
Q3 | $6.09M | Buy |
45,414
+26
| +0.1% | +$3.73K | 1.73% | 9 |
|
|
2022
Q2 | $6.95M | Sell |
45,388
-2,330
| -5% | -$356K | 1.88% | 8 |
|
|
2022
Q1 | $7.74M | Hold |
47,718
| – | – | 1.72% | 9 |
|
|
2021
Q4 | $6.46M | Sell |
47,718
-300
| -0.6% | -$35.4K | 1.38% | 11 |
|
|
2021
Q3 | $5.18M | Sell |
48,018
-750
| -2% | -$85.7K | 1.29% | 13 |
|
|
2021
Q2 | $5.49M | Hold |
48,768
| – | – | 1.35% | 13 |
|
|
2021
Q1 | $5.28M | Hold |
48,768
| – | – | 1.4% | 13 |
|
|
2020
Q4 | $5.22M | Sell |
48,768
-1,700
| -3% | -$163K | 1.38% | 13 |
|
|
2020
Q3 | $4.42M | Hold |
50,468
| – | – | 1.29% | 16 |
|
|
2020
Q2 | $4.95M | Buy |
50,468
+4,768
| +10% | +$420K | 1.67% | 12 |
|
|
2020
Q1 | $3.48M | Sell |
45,700
-200
| -0.4% | -$17K | 1.44% | 13 |
|
|
2019
Q4 | $4.06M | Sell |
45,900
-650
| -1% | -$54K | 1.35% | 16 |
|
|
2019
Q3 | $3.52M | Sell |
46,550
-200
| -0.4% | -$13.7K | 1.32% | 17 |
|
|
2019
Q2 | $3.4M | Sell |
46,750
-4,000
| -8% | -$314K | 1.31% | 19 |
|
|
2019
Q1 | $4.09M | Sell |
50,750
-2,400
| -5% | -$196K | 1.6% | 14 |
|
|
2018
Q4 | $4.9M | Sell |
53,150
-1,200
| -2% | -$106K | 2.12% | 14 |
|
|
2018
Q3 | $5.14M | Sell |
54,350
-50
| -0.1% | -$4.74K | 1.81% | 14 |
|
|
2018
Q2 | $5.04M | Hold |
54,400
| – | – | 1.98% | 15 |
|
|
2018
Q1 | $5.15M | Sell |
54,400
-100
| -0.2% | -$11K | 2.05% | 13 |
|
|
2017
Q4 | $5.27M | Hold |
54,500
| – | – | 2.05% | 13 |
|
|
2017
Q3 | $4.84M | Buy |
54,500
+200
| +0.4% | +$15.2K | 2.01% | 12 |
|
|
2017
Q2 | $3.94M | Sell |
54,300
-2,000
| -4% | -$134K | 1.7% | 15 |
|
|
2017
Q1 | $3.67M | Hold |
56,300
| – | – | 1.56% | 16 |
|
|
2016
Q4 | $3.52M | Hold |
56,300
| – | – | 1.63% | 17 |
|
|
2016
Q3 | $3.55M | Hold |
56,300
| – | – | 1.64% | 17 |
|
|
2016
Q2 | $3.48M | Sell |
56,300
-200
| -0.4% | -$12.2K | 1.69% | 17 |
|
|
2016
Q1 | $3.23M | Buy |
56,500
+250
| +0.4% | +$13.9K | 1.56% | 19 |
|
|
2015
Q4 | $3.33M | Hold |
56,250
| – | – | 1.61% | 16 |
|
|
2015
Q3 | $3.06M | Sell |
56,250
-100
| -0.2% | -$6.51K | 1.52% | 18 |
|
|
2015
Q2 | $3.79M | Hold |
56,350
| – | – | 1.71% | 14 |
|
|
2015
Q1 | $3.3M | Sell |
56,350
-3,200
| -5% | -$193K | 1.5% | 19 |
|
|
2014
Q4 | $3.9M | Sell |
59,550
-600
| -1% | -$37.8K | 1.72% | 15 |
|
|
2014
Q3 | $3.47M | Sell |
60,150
-300
| -0.5% | -$16.7K | 1.56% | 18 |
|
|
2014
Q2 | $3.41M | Sell |
60,450
-600
| -1% | -$31.5K | 1.54% | 18 |
|
|
2014
Q1 | $3.14M | Sell |
61,050
-200
| -0.3% | -$10.1K | 1.51% | 21 |
|
|
2013
Q4 | $3.23M | Hold |
61,250
| – | – | 1.56% | 20 |
|
|
2013
Q3 | $2.74M | Sell |
61,250
-800
| -1% | -$35.5K | 1.44% | 21 |
|
|
2013
Q2 | $2.56M | Buy |
+62,050
| New | +$2.71M | 1.41% | 23 |
|
Other funds holding ABBV
Independent Investors Inc's ABBV Position: Q2 2026 in Review
Independent Investors Inc reduced its AbbVie (ABBV) stake by 9.8% in Q2 2026, selling an estimated $947K and leaving 40,274 shares worth $10.1M. The position accounts for 1.94% of the portfolio, ranked #6.
Independent Investors Inc first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.5M in Q3 2025. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Independent Investors Inc held 40,274 shares of AbbVie worth $10.1M as of Q2 2026.
- Independent Investors Inc sold 4,400 AbbVie shares in Q2 2026, an estimated $947K.
- AbbVie made up 1.94% of Independent Investors Inc's portfolio in Q2 2026, its #6 holding.
- Independent Investors Inc first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Independent Investors Inc's AbbVie position peaked at $10.5M in Q3 2025.
- 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Independent Investors Inc's 13F filing for Q2 2026, filed 16 Jul 2026.